A Single-Center Experience on the Treatment Outcomes of Patients with COVID-19-Pleural Disorders: Lessons for the Future

Једноставна страница ставке
dc.citation.epage349
dc.citation.spage345
dc.citation.volume77
dc.contributor.authorAlihodzic-Pasalic, Alma
dc.contributor.authorPilav, Ilijaz
dc.contributor.authorMaric, Veljko
dc.contributor.authorKadic, Kenan
dc.contributor.authorDapcevic, Meho
dc.contributor.authorHadzismailovic, Ademir
dc.contributor.authorPilav, Alen
dc.contributor.authorAdemovic, Enisa
dc.contributor.authorCustovic, Orhan
dc.date.accessioned2024-12-18T12:05:28Z
dc.date.available2024-12-18T12:05:28Z
dc.date.issued2023
dc.description.abstractBackground: Pleural disorders in novel coronavirus disease 2019 (COVID-19), responsible for the deaths of more than 6.7 million people worldwide, are relatively uncommon and underappreciated findings. The severity of the pleural disease in these patients correlates with the treatment outcome and overall prognosis. Objective: We aim to review our experience with treatment modalities and prognosis in 45 patients with COVID-19, who were treated at our Clinic between April 2020 and October 2021. Methods: We conducted a retrospective, single-center, cross-sectional study. Demographic data, the type of thoracosurgical intervention(s), and treatment outcome for 45 patients included in this study were recorded for every patient. We analyzed the type and number of treatment modalities according to the pleural disorder, and the outcome of the treatment. Results: Pneumothorax was the most common COVID-19-related pleural disorder, followed by the pleural effusion. Tube thoracostomy was the mainstay of treatment, performed in 84.4% of patients with unilateral pleural complications. In total, 20% of our patients were on mechanical ventilation, and all of them had a fatal outcome. We found statistical significance in comparison to the percentage of fatal outcomes between patients treated with and without mechanical ventilation (p=0.000). Conclusion: COVID-19-related pleural disorders are prognostic markers of disease progression. Mechanically ventilated patients who require tube thoracostomy have an unfavorable prognosis.
dc.identifier.doi10.5455/medarh.2023.77.345-349
dc.identifier.urihttps://vaseljena.ues.rs.ba/handle/123456789/1409
dc.language.isoen
dc.publisherAcademy of Medical Sciences in Bosnia and Herzegovina
dc.sourceMedical Archives
dc.subjectpleural effusion, COVID-19, pneumothorax, thoracocentesis, chest tube.
dc.titleA Single-Center Experience on the Treatment Outcomes of Patients with COVID-19-Pleural Disorders: Lessons for the Future
dc.typeArticle
Датотеке
Оригинални завежљај
Сада се приказује 1 - 1 од 1
Сличица
Име:
A Single-Center Experience on the.pdf
Величина:
175.72 KB
Формат:
Adobe Portable Document Format
Опис:
Преузимање
Свежањ лиценце
Сада се приказује 1 - 1 од 1
Сличица
Име:
license.txt
Величина:
1.71 KB
Формат:
Item-specific license agreed to upon submission
Опис:
Преузимање
Колекције
Медицински факултет [Научни радови] / Faculty of Medicine [Scientific papers]